BioSpace News Archive

Establish Intellectual Property Partnership and $10 Million Strategic Equity Investment

IMV Inc. announced that it will hold a conference call and webcast on Friday, May 10, 2019 at 8:00 a.m. ET to discuss the company’s first quarter 2019 financial and operational results.

Neovasc Inc. provided highlights from the 85th Annual Conference of the German Society of Cardiology, which is taking place in Mannheim, Germany, April 24 – 27, 2019.

Submission to EMA follows Biologics Licensing Application submission to U.S. FDA earlier this month

pMD, the innovation leader in health care technology, has been recognized as a winner of the 2019 Bay Area Best Places to Work, an awards program presented by the San Francisco Business Times and the Silicon Valley Business Journal.

Encoda LLC, a leading healthcare reimbursement automation and revenue cycle management company announced today that the Alabama Orthopedic Clinic (AOC), a premier 21 physician orthopedic practice in Mobile, Alabama, recently implemented Encoda BackOffice™ and Encoda Maestro Analytics™ in their central billing office

Genexine, Inc. (Genexine) and NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the first patient has been dosed in a combination regimen trial to investigate the safety and efficacy of Hyleukin-7™, their T cell amplifier, in combination with Merck’s anti PD-1 therapy, KEYTRUDA

PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announces the expansion of its oncology franchise to include Precision Medicine.

International Hemp Exchange (IHE), a leader in the burgeoning U.S. hemp industry, and Seed2System, are proud to announce production of up to 10 million HGH feminized seed starts available for nationwide delivery this spring out of their Colorado nursery.

Baxter International Inc. (NYSE:BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access, Choice, and Equity (ACE) program will be expanded for a third year.